Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-10-09Clinical Trial Update: Manuka Eye Droops for Treatment of Allergy [Phase 4]
Phase 4 clinical trial for Manuka Eye Droops for allergic conjunctivitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-10-02Clinical Trial Update: Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial comparing PRO-118 to olopatadine for allergic conjunctivitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-20Clinical Trial Update: A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis [Phase 2]
A Phase 2 clinical trial evaluating a new treatment for allergic conjunctivitis has been withdrawn. The sponsor indicates the study will not…
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge [Phase 2]
Phase 2 trial of AL-38583 evaluating reduction of tear eosinophil count after conjunctival allergen challenge has been withdrawn. No efficac…
-
CLINICAL_TRIALS withdrawal · 2010-10-07Clinical Trial Update: Comparison of CL Wear Between Two Allergy Drops [Phase 4]
A phase 4 clinical trial comparing contact lens wear between two allergy eye drops was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2008-11-18EMA Application withdrawn: Vekacia (ciclosporin) — Novagali Pharma S.A.
The EMA withdrew the application for Vekacia (ciclosporin) by Novagali Pharma S.A. for allergic conjunctivitis.